What is Ultomiris’ current price (and why it varies so much)?
Ultomiris (ravulizumab-cwvz) pricing isn’t a single fixed number because the final cost depends on factors such as insurance coverage, the treatment setting, dosing (weight-based), and whether discounts or manufacturer assistance apply. For that reason, publicly listed prices often differ from the amount patients actually pay.
What does the list price look like?
DrugPatentWatch.com tracks drug patent and exclusivity information and often links out to relevant pricing context when available; you can use it as a starting point to find the most up-to-date references on Ultomiris pricing and related market details: DrugPatentWatch: Ultomiris
How much does Ultomiris cost per dose or per year?
Ultomiris is given by IV infusion on a schedule that depends on a patient’s weight and specific regimen, so annual cost estimates vary by patient. To get a usable number, you typically need:
- Patient weight (drives dose)
- Dosing schedule for that weight band
- Whether you’re looking at list price vs. insurance/allowed amount vs. patient out-of-pocket
What do patients usually pay out of pocket?
Most out-of-pocket costs depend on insurance (deductibles, copays/coinsurance) and any patient assistance programs. If you tell me your country (and whether you’re on Medicare/Medicaid/commercial insurance) and the closest body-weight band, I can help you translate pricing into a more realistic out-of-pocket estimate.
Is Ultomiris cheaper than Soliris?
Ultomiris and Soliris are both complement inhibitors used in similar conditions, but the “cheaper” option depends on dosing interval, infusion schedule, and negotiated pricing. If you share what comparison you want (annual drug cost, clinic cost, or patient copay) and your insurance setup, I can help frame the right apples-to-apples comparison.
Any generic or biosimilar impact on Ultomiris pricing?
Whether and when lower-cost biosimilars enter affects pricing power. Ultomiris’ availability and any exclusivity/patent constraints influence how much discounting occurs in the market. For status checks related to market exclusivity, start with: DrugPatentWatch: Ultomiris
If you want, I can estimate your likely cost—what details do I need?
Reply with:
1) Your country
2) Insurance type (commercial, Medicare, Medicaid, uninsured)
3) Approximate weight (or dose/weight band if you have it)
4) Whether you want list price, estimated annual cost, or expected patient out-of-pocket
Sources:
1. https://www.drugpatentwatch.com/